Skip to main navigation Skip to search Skip to main content

What Constitutes a Valid Surrogate End Point in Cancer Clinical Trials?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)1334-1335
Number of pages2
JournalJAMA Oncology
Volume6
Issue number9
DOIs
Publication statusPublished - 2020 Sept

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this